● Recruiting

PI-YSP-0111 Formulation on Human Gut Microbiota and Body Composition

Condition: Heathly Volunteers · Sponsor: Taipei Medical University

PhaseNA

Planned participants140

Who can joinAll sexes, 18 Years to 65 Years

Healthy volunteersYes

About this study

The expected outcome of this study is that continuous 8-week supplementation with the PI-YSP-0111 prebiotic formulation will exert beneficial effects on gut microbiota modulation and liver health.

This description comes directly from the study's public registry record.

Talk to the study team

Ming Ta Yang, Professor · +886-2-27361661 · yangrugby@tmu.edu.tw

Always discuss trial participation with your own doctor first.

Locations (2)

Taipei Medical University	Taipei, Taiwan, Taiwan	Recruiting
Taipei Municipal WanFang Hospital(Managed by Taipei Medical University)	Taipei, Taiwan, Taiwan	Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07618000